A significant shift in our drug policy has taken place, as the government permit the use of psilocybin fungi for therapeutic applications. Previously, these substances were heavily restricted, but a increasing body of studies suggests they potentially offer benefits for emotional illnesses like PTSD. This change represents a substantial step toward